amikacin has been researched along with Body Weight in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (53.33) | 18.7374 |
1990's | 6 (13.33) | 18.2507 |
2000's | 4 (8.89) | 29.6817 |
2010's | 10 (22.22) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Chaudhari, BB; Dillibatcha, J; Lewis, LE; Mallayasamy, S; Matcha, S; Moorkoth, S; Raju, AP | 1 |
Illamola, SM; Sherwin, CM; van Hasselt, JGC | 1 |
Endo, A; Hanawa, K; Hasebe, Y; Isobe, K; Kobayashi, M; Kobayashi, Y; Maebayashi, Y; Naito, A; Nemoto, A; Yamamoto, S | 1 |
Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
Bourguignon, L; Ducher, M; Maire, P; Rughoo, L | 1 |
Bouadma, L; Chemam, S; de Montmollin, E; Gault, N; Mariotte, E; Massias, L; Mourvillier, B; Papy, E; Sonneville, R; Tubach, F; Wolff, M | 1 |
De Rosa, FG; Roberts, JA | 1 |
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL | 1 |
Broadbent, RS; Medlicott, NJ; Reith, DM; Sherwin, CM; Svahn, S; Van der Linden, A | 1 |
Bourguignon, L; Debeurme, G; Ducher, M; Jean-Bart, E | 1 |
Bhandari, JC; Donikian, MR; Drobeck, HP; Fabian, RJ; Montenaro, MJ; Slighter, RG | 1 |
Akutsu, S; Asano, M; Hirata, A; Ishikawa, H; Matsumoto, H; Matsuzaki, M; Nakamura, K; Nakata, Y; Samura, K | 1 |
Akutsu, S; Fukushima, Y; Katoh, M; Kawana, K; Matsuzaki, M; Shimamura, T | 1 |
Akutsu, S; Asano, M; Fukushima, Y; Komatsu, H; Matsumoto, H; Matsuzaki, M; Samura, K; Shimamura, T | 1 |
Arpini, A; Bamonte, F; Marzanatti, M; Ongini, E; Parravicini, L | 1 |
Hallynck, T; Pijck, J; Soep, H | 1 |
Blevins, R; Bockbrader, H; Matzke, GR; Salem, N | 1 |
Bauer, LA; Bell, RM; Blouin, RA; Griffen, WO; Record, KE | 1 |
Boelaert, J; Daneels, R; Fillastre, JP; Hallynck, TH; Reeves, DS; Rubinstein, E; Soep, HH; Thomis, JA | 1 |
Barbaut, X; Berod, T; Girard, P; Jelliffe, RW; Maire, P; Mallet, A | 1 |
Bouvet, O; Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Fabre, D; Galtier, M; Kinowski, JM; Saissi, G | 1 |
Bamonte, F; Dionisotti, S; Fredelius, L; Ongini, E; Wersäll, J | 1 |
Bancroff, G; Bucke, W; Ehlers, S; Fortmann, L; Hahn, H; Hänsch, H; Leitzke, S; Müller, R; Smith, D | 1 |
Aulagner, G; Bleyzac, N; Boutroy, MJ; Jelliffe, RW; Labaune, JM; Maire, P; Putet, G | 1 |
Aulagner, G; Bleyzac, N; Corvaisier, S; Jelliffe, RW; Labaune, JM; Maire, P; Putet, G; Varnier, V | 1 |
Merlé, Y; Pons, G; Rey, E; Tonnelier, S; Tréluyer, JM | 1 |
Kafetzis, DA; Kosmidis, J; Papadatos, CJ; Sinaniotis, CA | 1 |
Hull, JH; Sarubbi, FA | 1 |
Akiyoshi, M; Akutsu, S; Matsuzaki, M; Tajima, T; Yano, S | 1 |
Kowarski, AA; Lietman, PS; Vogelstein, B | 1 |
Akiyoshi, M; Nakada, H; Sato, K; Suzuki, K; Tajima, T | 1 |
Aizawa, T; Akutsu, S; Matsuzaki, M; Mukogawa, H | 1 |
Akutsu, S; Matsuzaki, M; Mukogawa, H; Shimamura, T | 1 |
Akutsu, S; Hirata, A; Matsuzaki, M; Nakamura, K; Sekino, M | 1 |
Iimo, K; Matsuzaki, M; Nakamura, K; Sekino, M; Yoshida, A | 1 |
Akutsu, S; Matsuzaki, M; Onodera, K; Sekino, M; Yoshida, A | 1 |
Akutsu, S; Matsuzaki, M; Nakamura, K; Sekino, M; Yoshida, A | 1 |
Brown, AC; Huggins, ML; Iliadis, A | 1 |
Davis, RL; Lehmann, D; Neidhart, J; Stidley, CA | 1 |
Endo, H; Matsumoto, K; Miura, M; Morino, T; Sano, K; Shiraiwa, K; Yamamoto, H | 1 |
Job, ML; Murphy, JE; Peltier, TT; Tointon, MM; Ward, ES | 1 |
Armstrong, DK; Dasta, JF | 1 |
Adejuyigbe, O; Provoost, AP; Wolff, ED | 1 |
Hu, X; Li, T; Liu, J; Ou-Yang, Q; Wang, L; Xie, X | 1 |
Hesta, M; Janssens, GP; Rochus, K; Van de Velde, H; Vanhaecke, L; Verbrugghe, A; Wuyts, B | 1 |
1 review(s) available for amikacin and Body Weight
Article | Year |
---|---|
Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses.
Topics: Adolescent; Age Factors; Amikacin; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Humans; Infant; Metabolic Clearance Rate; Models, Biological; Tissue Distribution | 2018 |
2 trial(s) available for amikacin and Body Weight
Article | Year |
---|---|
Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Kidney; Metabolic Clearance Rate; Models, Biological; Statistics, Nonparametric | 2001 |
APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.
Topics: Amikacin; Bayes Theorem; Body Weight; Drug Administration Schedule; Drug Costs; Drug Monitoring; France; Gram-Negative Bacterial Infections; Humans; Software Validation | 1992 |
42 other study(ies) available for amikacin and Body Weight
Article | Year |
---|---|
Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
Topics: Amikacin; Anti-Bacterial Agents; Body Weight; Creatinine; Humans; Infant, Newborn; Models, Biological | 2023 |
Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Body Weight; Brain Stem; Creatinine; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Kidney; Male; Otorhinolaryngologic Diseases; Respiratory Tract Infections | 2019 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Study of relationship between volume of distribution and body weight application to amikacin.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Body Weight; Female; Humans; Male; Middle Aged; Retrospective Studies | 2014 |
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Body Mass Index; Body Weight; Critical Illness; Dose-Response Relationship, Drug; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Injections; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors | 2014 |
Amikacin dosing in the ICU: we now know more, but still not enough….
Topics: Amikacin; Anti-Bacterial Agents; Body Weight; Female; Humans; Male | 2014 |
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant | 2015 |
Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis.
Topics: Amikacin; Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Menstruation; Metabolic Clearance Rate; Models, Biological; Reproducibility of Results; Risk Factors; Sepsis; Time Factors; Treatment Failure | 2009 |
[Calculation of the first dose of amikacine: evaluation of the current dosage recommendations].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Guidelines as Topic; Humans; Male; Reference Standards; Software | 2013 |
Comparative nephrotoxicity of hydroxygentamicin and other aminoglycosides in rats.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Body Weight; Creatinine; Gentamicins; Kidney Diseases; Kidney Function Tests; Male; Netilmicin; Organ Size; Rats; Rats, Inbred F344 | 1984 |
[Toxicological study of amikacin following intravenous drip infusion. 1. Acute toxicity in rats, rabbits and dogs, and subacute toxicity in rabbits].
Topics: Amikacin; Animals; Blood Chemical Analysis; Body Weight; Dogs; Drinking; Eating; Electrocardiography; Female; Hearing; Hematologic Tests; Infusions, Parenteral; Injections, Intravenous; Kanamycin; Kidney; Lethal Dose 50; Male; Organ Size; Rabbits; Rats; Rats, Inbred Strains | 1982 |
[Effects of intravenous infusion of amikacin. Intraperitoneal administration to rats before and in the early stage of pregnancy. Segment 1].
Topics: Amikacin; Animals; Body Weight; Bone and Bones; Drinking; Eating; Female; Fertility; Fetus; Injections, Intraperitoneal; Kanamycin; Kidney; Male; Pregnancy; Rats | 1982 |
[Toxicological study of amikacin following intravenous drip infusion. 2. Subacute toxicity in dogs after intravenous injection].
Topics: Amikacin; Animals; Blood Chemical Analysis; Body Weight; Dogs; Drinking; Eating; Electrocardiography; Female; Hearing; Hematologic Tests; Injections, Intravenous; Kanamycin; Kidney; Kidney Function Tests; Liver Function Tests; Male; Organ Size | 1982 |
Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Body Weight; Cochlea; Ear Diseases; Electrophysiology; Female; Gentamicins; Guinea Pigs; Hearing Disorders; Male; Netilmicin; Tobramycin | 1982 |
Influence of age and lean body mass on the relation of creatinine clearance and drug half-life.
Topics: Adolescent; Aging; Amikacin; Body Weight; Child; Child, Preschool; Creatinine; Female; Gentamicins; Half-Life; Humans; Infant; Infant, Newborn; Kidney Diseases; Liver; Male; Pharmaceutical Preparations | 1982 |
The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
Topics: Aged; Amikacin; Bacterial Infections; Body Weight; Female; Half-Life; Humans; Kanamycin; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Peritoneal Dialysis | 1980 |
Amikacin pharmacokinetics in morbidly obese patients.
Topics: Adult; Amikacin; Body Weight; Female; Humans; Kanamycin; Kinetics; Male; Middle Aged; Models, Biological; Obesity | 1980 |
Lean body mass and amikacin dosage.
Topics: Adolescent; Adult; Aged; Amikacin; Body Weight; Humans; Kanamycin; Middle Aged; Skin Physiological Phenomena | 1980 |
Preliminary results of three methods for population pharmacokinetic analysis (NONMEM, NPML, NPEM) of amikacin in geriatric and general medicine patients.
Topics: Aged; Aged, 80 and over; Amikacin; Body Weight; Creatinine; Drug Monitoring; Drug Therapy, Computer-Assisted; Humans; Middle Aged; Models, Biological; Models, Chemical; Tissue Distribution | 1994 |
Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.
Topics: Adult; Aged; Amikacin; Body Weight; Ceftazidime; Critical Care; Drug Administration Schedule; Female; Hemofiltration; Humans; Infusions, Intravenous; Male; Middle Aged; Multiple Organ Failure; Shock, Septic; Software | 1993 |
Auditory impairment in guinea pigs treated with isepamicin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Auditory Threshold; Body Weight; Brain; Cochlear Duct; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Hearing Disorders; Male; Microscopy, Electron, Scanning | 1995 |
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.
Topics: Amikacin; Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Granuloma; Injections, Intravenous; Liposomes; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mycobacterium avium; Time Factors; Tuberculosis | 1996 |
Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
Topics: Amikacin; Bacterial Infections; Body Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Kidney | 2001 |
Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children.
Topics: Age Factors; Amikacin; Anti-Bacterial Agents; Apgar Score; Body Weight; Creatinine; Female; Gestational Age; Humans; Infant; Infant, Newborn; Male; Population Surveillance; Statistics, Nonparametric | 2002 |
Pharmacokinetics of amikacin in infants and pre-school children.
Topics: Age Factors; Amikacin; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Male; Time Factors | 1979 |
Amikacin serum concentrations: prediction of levels and dosage guidelines.
Topics: Adult; Amikacin; Body Weight; Computers; Creatinine; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Kidney Diseases; Mathematics | 1978 |
[Ototoxic effect of BB-K8 administered to pregnant guinea pigs on development of inner ear of intrauterine litters (author's transl)].
Topics: Amikacin; Animals; Animals, Newborn; Body Weight; Ear, Inner; Female; Fetus; Guinea Pigs; Kanamycin; Maternal-Fetal Exchange; Pregnancy; Reflex | 1977 |
Continuous sampling as a pharmacokinetic tool.
Topics: Adolescent; Amikacin; Blood Specimen Collection; Body Weight; Child; Child, Preschool; Half-Life; Humans; Kinetics; Models, Biological; Pharmaceutical Preparations | 1977 |
[Evaluation of ototoxicity of amikacin (BB-K8) by animal test (author's transl)].
Topics: Amikacin; Animals; Auditory Threshold; Body Weight; Gentamicins; Guinea Pigs; Hearing; Hearing Disorders; Injections, Intramuscular; Kanamycin; Organ of Corti | 1975 |
[Teratological studies of amikacin (BB-K8) in rabbit (author's transl)].
Topics: Abnormalities, Drug-Induced; Amikacin; Animals; Body Weight; Embryo Implantation; Female; Fetus; Injections, Intramuscular; Kanamycin; Osteogenesis; Pregnancy; Rabbits | 1975 |
[Teratological studies of amikacin (BB-K8) in mice and rats (author's transl)].
Topics: Abnormalities, Drug-Induced; Amikacin; Animals; Animals, Newborn; Body Weight; Drinking; Feeding Behavior; Female; Fetus; Growth; Injections, Intradermal; Kanamycin; Kidney Diseases; Mice; Osteogenesis; Pregnancy; Rats | 1975 |
[Studies on the toxicity of amikacin (BB-K8), I. Acute toxicity and subacute toxicity in rats (author's transl)].
Topics: Administration, Oral; Amikacin; Animals; Blood Urea Nitrogen; Body Weight; Dilatation, Pathologic; Drinking; Feeding Behavior; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Kanamycin; Kidney; Kidney Tubules; Lethal Dose 50; Male; Mice; Organ Size; Rabbits; Rats | 1975 |
[Studies on the toxicity of amikacin (BB-K8).II. Chronic toxicity in rats (author's transl)].
Topics: Amikacin; Animals; Blood Urea Nitrogen; Body Weight; Dilatation, Pathologic; Drinking; Drug Evaluation, Preclinical; Feeding Behavior; Female; Injections, Subcutaneous; Kanamycin; Kidney; Kidney Tubules; Male; Organ Size; Rats; Sex Factors | 1975 |
[Studies on the toxicity of amikacin (BB-K8),III. Subacute toxicity of amikacin (BB-K8) in dogs (author's transl)].
Topics: Acute Disease; Amikacin; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Dilatation, Pathologic; Dogs; Drinking; Drug Evaluation, Preclinical; Feeding Behavior; Female; Injections, Intramuscular; Kanamycin; Kidney Diseases; Kidney Tubules; Male; Sex Factors | 1975 |
[Studies on the toxicity of amikacin (BB-K8). Chronic toxicity in dogs (author's transl)].
Topics: Amikacin; Animals; Anorexia; Blood Urea Nitrogen; Body Weight; Creatinine; Dogs; Drinking; Drug Evaluation, Preclinical; Feeding Behavior; Female; Injections, Intramuscular; Kanamycin; Leukocyte Count; Male; Sex Factors | 1975 |
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Agents; Body Weight; Female; Half-Life; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Regression Analysis | 1991 |
[Toxicological studies on isepamicin (HAPA-B). II. Intramuscular subacute toxicity test in the rat].
Topics: Amikacin; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Rats | 1986 |
Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
Topics: Adult; Aged; Amikacin; Body Weight; Female; Gentamicins; Humans; Male; Middle Aged; Retrospective Studies; Tobramycin | 1987 |
More on variability in aminoglycoside volume of distribution.
Topics: Adult; Aged; Amikacin; Body Weight; Critical Care; Gentamicins; Humans; Middle Aged; Surgical Procedures, Operative; Tobramycin | 1987 |
Nephrotoxicity of aminoglycosides in young and adult rats.
Topics: Age Factors; Amikacin; Animals; Biological Transport, Active; Body Weight; Gentamicins; Glomerular Filtration Rate; Kanamycin; Kidney; Kidney Tubules, Proximal; Male; Organ Size; Rats; Rats, Inbred Strains | 1985 |
AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Topics: AMP-Activated Protein Kinases; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Gene Expression; Isoproterenol; Male; Natriuretic Peptide, Brain; Organ Size; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Piperidines; Rats, Sprague-Dawley; Signal Transduction; Thyroxine | 2019 |
Highly viscous guar gum shifts dietary amino acids from metabolic use to fermentation substrate in domestic cats.
Topics: Amino Acids; Animals; Body Weight; Butyric Acid; Carnitine; Cats; Cellulose; Cross-Over Studies; Diet; Dietary Fiber; Dietary Proteins; Digestion; Energy Intake; Fatty Acids, Volatile; Feces; Female; Fermentation; Galactans; Intestinal Mucosa; Male; Mannans; Plant Gums; Viscosity | 2013 |